Engineered T cells for cancer therapy

被引：95

作者：

June, Carl H. ^{[1
,2
]}

Maus, Marcela V. ^{[1
,3
]}

Plesa, Gabriela ^{[1
]}

Johnson, Laura A. ^{[1
,2
]}

Zhao, Yangbing ^{[1
,2
]}

Levine, Bruce L. ^{[1
,2
]}

Grupp, Stephan A. ^{[1
,4
]}

Porter, David L. ^{[1
,3
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[3] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA

[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

来源：

CANCER IMMUNOLOGY IMMUNOTHERAPY | 2014年 / 63卷 / 09期

关键词：

Adoptive cell transfer; Gene transfer; Leukemia; Chimeric antigen receptor; 19th Danish Cancer Society Symposium; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; GENE-THERAPY; TOXICITY; REGRESSION; CD28; SPECIFICITY; PERSISTENCE; ACTIVATION; EXPRESSION;

D O I：

10.1007/s00262-014-1568-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities, is the subject of this focused research review.

引用

页码：969 / 975

页数：7

共 50 条

[31] Engineered T cells: the promise and challenges of cancer immunotherapy
Andrew D. Fesnak
Carl H. June
Bruce L. Levine
Nature Reviews Cancer, 2016, 16 : 566 - 581
[32] Engineered T-cell Receptor T Cells for Cancer Immunotherapy
Greenbaum, Uri
Dumbrava, Ecaterina, I
Biter, Amadeo B.
Haymaker, Cara L.
Hong, David S.
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (11) : 1252 - 1261
[33] Using T cell receptor engineered T cells for the treatment of cancer
Morgan, R. A.
CANCER RESEARCH, 2013, 73
[34] Improving the efficacy and safety of engineered T cell therapy for cancer
Shi, Huan
Liu, Lin
Wang, Zhehai
CANCER LETTERS, 2013, 328 (02) : 191 - 197
[35] Autologous engineered T cell receptor therapy in advanced cancer
Tsimberidou, Apostolia M.
Baysal, Mehmet A.
Chakraborty, Abhijit
Andersson, Borje S.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
[36] Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
Ren, Yan-Bei
Sun, Shang-Jun
Han, Shuang-Yin
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (01) : 78 - 83
[37] CRISPR-engineered T cells in patients with refractory cancer
Stadtmauer, Edward A.
Fraietta, Joseph A.
Davis, Megan M.
Cohen, Adam D.
Weber, Kristy L.
Lancaster, Eric
Mangan, Patricia A.
Kulikovskaya, Irina
Gupta, Minnal
Chen, Fang
Tian, Lifeng
Gonzalez, Vanessa E.
Xu, Jun
Jung, In-young
Melenhorst, J. Joseph
Plesa, Gabriela
Shea, Joanne
Matlawski, Tina
Cervini, Amanda
Gaymon, Avery L.
Desjardins, Stephanie
Lamontagne, Anne
Salas-Mckee, January
Fesnak, Andrew
Siegel, Donald L.
Levine, Bruce L.
Jadlowsky, Julie K.
Young, Regina M.
Chew, Anne
Hwang, Wei-Ting
Hexner, Elizabeth O.
Carreno, Beatriz M.
Nobles, Christopher L.
Bushman, Frederic D.
Parker, Kevin R.
Qi, Yanyan
Satpathy, Ansuman T.
Chang, Howard Y.
Zhao, Yangbing
Lacey, Simon F.
June, Carl H.
SCIENCE, 2020, 367 (6481) : 1001 - +
[38] The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy
Bedoya, Felipe
Frigault, Matthew J.
Maus, Marcela V.
MOLECULAR THERAPY, 2017, 25 (02) : 314 - 320
[39] Editorial: Translation of genetically engineered T cells in cancer immunotherapy
Voss, Ralf-Holger
Echchannaoui, Hakim
Huang, He
Xue, Shao-An
FRONTIERS IN IMMUNOLOGY, 2023, 14
[40] Overcoming key challenges in cancer immunotherapy with engineered T cells
Arcangeli, Silvia
Mestermann, Katrin
Weber, Justus
Bonini, Chiara
Casucci, Monica
Hudecek, Michael
CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 398 - 407

← 1 2 3 4 5 →